Corebridge Financial’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-92,571	Closed	-$133K	–	901
2025 Q1	$133K	Sell	92,571 -1,373	-1%	-$1.98K	﹤0.01%	2286
2024 Q4	$207K	Sell	93,944 -7,091	-7%	-$15.6K	﹤0.01%	2161
2024 Q3	$167K	Sell	101,035 -623	-0.6%	-$1.03K	﹤0.01%	2321
2024 Q2	$227K	Buy	+101,658	New	+$227K	﹤0.01%	2116